These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9469795)

  • 1. Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin-dependent diabetic patients.
    Earle KA; Morocutti A; Viberti G
    J Hypertens; 1997 Feb; 15(2):191-6. PubMed ID: 9469795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents.
    Walker JD; Tariq T; Viberti G
    BMJ; 1990 Sep; 301(6753):635-8. PubMed ID: 2224216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport.
    Carr S; Mbanya JC; Thomas T; Keavey P; Taylor R; Alberti KG; Wilkinson R
    N Engl J Med; 1990 Feb; 322(8):500-5. PubMed ID: 2300121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy.
    Jensen JS; Mathiesen ER; Nørgaard K; Hommel E; Borch-Johnsen K; Funder J; Brahm J; Parving HH; Deckert T
    Diabetologia; 1990 Oct; 33(10):619-24. PubMed ID: 2257999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy.
    Mangili R; Bending JJ; Scott G; Li LK; Gupta A; Viberti G
    N Engl J Med; 1988 Jan; 318(3):146-50. PubMed ID: 3336402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Tohoku J Exp Med; 1990 Aug; 161(4):311-8. PubMed ID: 2256104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes.
    Hasslacher C; Stech W; Wahl P; Ritz E
    Diabetologia; 1985 Jan; 28(1):6-11. PubMed ID: 3979689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predisposition to essential hypertension and the development of diabetic nephropathy.
    Viberti GC; Earle K
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S27-33. PubMed ID: 1457758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
    Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
    Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.
    Rave K; Bender R; Heise T; Sawicki PT
    J Hypertens; 1999 May; 17(5):597-601. PubMed ID: 10403602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.
    Krolewski AS; Canessa M; Warram JH; Laffel LM; Christlieb AR; Knowler WC; Rand LI
    N Engl J Med; 1988 Jan; 318(3):140-5. PubMed ID: 3336401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.
    Evans M; Bain SC; Hogan S; Bilous RW;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2255-63. PubMed ID: 22172728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control.
    Bending JJ; Viberti GC; Watkins PJ; Keen H
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):83-6. PubMed ID: 3080101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.